I was just medling with medical archives to learn more about David Stamler.
He was the chief medical officer of Auspex which got bought by Teva for $3.5B. SD-809 was the lead candidate drug for treating chorea. The drug got FDA approval in 2017
This impeccable record could be the reason Stamler is paid a hefty salary. I will not be surprised if ATH434 walks in the footsteps of SD-809
I will wait until the end. I'm not releasing my shares.
- Forums
- ASX - By Stock
- Ann: Alterity Therapeutics Raises $4.8M AUD in Placement
I was just medling with medical archives to learn more about...
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $5.012K | 1.294M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
43 | 54662006 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126993867 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
42 | 54412006 | 0.003 |
55 | 84168098 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 125993867 | 28 |
0.005 | 25809782 | 26 |
0.006 | 12956477 | 18 |
0.007 | 47601651 | 22 |
0.008 | 22833132 | 23 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online